Endocrinology, Vol 132, 725-734, Copyright © 1993 by Endocrine Society

ARTICLES

Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats

TK Woodruff, L Krummen, SA Chen, R Lyon, SE Hansen, G DeGuzman, R Covello, J Mather and P Cossum
Department of Cell Culture and Fermentation Research and Development, Genentech Inc., South San Francisco, California 94080.

The tissue distribution of recombinant human inhibin A (rh-inhibin A) and rh-activin A was determined in immature female Sprague Dawley- derived rats after iv administration of radiolabeled proteins. [125I]rh- Inhibin A and [125I]rh-activin A diverge in their distribution to tissues of the immature female rat as examined histologically (whole body autoradiography and thin section analysis) and by computing the percent dose and tissue to blood ratios for individual tissues. [125I]rh-inhibin A accumulated in the spleen, adrenal, bone marrow, and ovary after iv injection. Iodinated rh-inhibin A was also found in the anterior and posterior pituitary. [125I]rh-activin A was found in the ovary and pituitary after iv injection. Little specific binding was found in the spleen or adrenal. The bone marrow accumulated some [125I]rh-activin A which was competed by rh-activin A. The primary route of excretion for radioactivity was the kidney, with the label appearing in the bladder by 10 min after iv injection. Not only do rh- inhibin A and rh-activin A have different pharmacokinetics, but fewer tissues accumulate radioactive rh-activin A than rh-inhibin A.

This article has been cited by other articles:

				D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al. Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength Endocrinology, April 1, 2007; 148(4): 1654 - 1665. [Abstract] [Full Text] [PDF]

				P. G Farnworth, Y. Wang, P. Leembruggen, G. T Ooi, C. Harrison, D. M Robertson, and J. K Findlay Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. J. Endocrinol., March 1, 2006; 188(3): 451 - 465. [Abstract] [Full Text] [PDF]

				F. Beuschlein, B. D. Looyenga, S. E. Bleasdale, C. Mutch, D. L. Bavers, A. F. Parlow, J. H. Nilson, and G. D. Hammer Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice Mol. Cell. Biol., June 1, 2003; 23(11): 3951 - 3964. [Abstract] [Full Text] [PDF]

				B. Schmierer, M. K. Schuster, A. Shkumatava, and K. Kuchler Activin A Signaling Induces Smad2, but Not Smad3, Requiring Protein Kinase A Activity in Granulosa Cells from the Avian Ovary J. Biol. Chem., May 30, 2003; 278(23): 21197 - 21203. [Abstract] [Full Text] [PDF]

				C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]

				T. Vanttinen, T. Kuulasmaa, J. Liu, and R. Voutilainen Expression of Activin/Inhibin Receptor and Binding Protein Genes and Regulation of Activin/Inhibin Peptide Secretion in Human Adrenocortical Cells J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4257 - 4263. [Abstract] [Full Text] [PDF]

				D. Gaddy-Kurten, J. K. Coker, E. Abe, R. L. Jilka, and S. C. Manolagas Inhibin Suppresses and Activin Stimulates Osteoblastogenesis and Osteoclastogenesis in Murine Bone Marrow Cultures Endocrinology, January 1, 2002; 143(1): 74 - 83. [Abstract] [Full Text] [PDF]

				T. M. Pierson, Y. Wang, F. J. DeMayo, M. M. Matzuk, S. Y. Tsai, and B. W. O’Malley Regulable Expression of Inhibin A in Wild-Type and Inhibin {alpha} Null Mice Mol. Endocrinol., July 1, 2000; 14(7): 1075 - 1085. [Abstract] [Full Text]

				W. Chen, T. K. Woodruff, and K. E. Mayo Activin A-Induced HepG2 Liver Cell Apoptosis: Involvement of Activin Receptors and Smad Proteins Endocrinology, March 1, 2000; 141(3): 1263 - 1272. [Abstract] [Full Text] [PDF]

				R. Hertan, P. G. Farnworth, K. L. Fitzsimmons, and D. M. Robertson Identification of High Affinity Binding Sites for Inhibin on Ovine Pituitary Cells in Culture Endocrinology, January 1, 1999; 140(1): 6 - 12. [Abstract] [Full Text]

				E. Y. Wang, L. B. Draper, E. Lee, A. Polak, P. Sluss, J. Weiss, and T. K. Woodruff Identification of Naturally Occurring Follistatin Complexes in Human Biological Fluids Biol Reprod, January 1, 1999; 60(1): 8 - 13. [Abstract] [Full Text]

				L. B. Draper, H. Chong, E. Wang, and T. K. Woodruff The Uterine Myometrium Is a Target for Increased Levels of Activin A during Pregnancy Endocrinology, July 1, 1997; 138(7): 3042 - 3046. [Abstract] [Full Text] [PDF]